Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BNLE Access Guidewire

K-Number: K221390 · 2023-04-28

ApplicantBiomerics Nle
Decision Date2023-04-28
Product CodeDQX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

BNLE Access Guidewire is a medical device manufactured by Biomerics Nle. It received FDA 510(k) clearance on 2023-04-28 under approval number K221390. The device is classified under product code DQX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BNLE Access Guidewire?

BNLE Access Guidewire is a medical device that received FDA 510(k) clearance on 2023-04-28. It is manufactured by Biomerics Nle. The 510(k) number is K221390.

When was BNLE Access Guidewire approved by the FDA?

BNLE Access Guidewire received FDA 510(k) clearance on 2023-04-28, under approval number K221390.

What company makes BNLE Access Guidewire?

BNLE Access Guidewire is manufactured by Biomerics Nle.

What is the FDA product code for BNLE Access Guidewire?

The FDA product code for BNLE Access Guidewire is DQX.

Related Clinical Trials

Other Devices by Biomerics Nle

Related Devices (Code: DQX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.